nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR2—Thalidomide—leprosy	0.494	0.627	CbGbCtD
Ponatinib—ABCB11—Rifampicin—leprosy	0.114	0.145	CbGbCtD
Ponatinib—CYP3A5—Thalidomide—leprosy	0.031	0.0394	CbGbCtD
Ponatinib—CYP3A5—Rifampicin—leprosy	0.0301	0.0381	CbGbCtD
Ponatinib—CYP2C8—Rifampicin—leprosy	0.0289	0.0367	CbGbCtD
Ponatinib—CYP3A5—Dapsone—leprosy	0.0248	0.0315	CbGbCtD
Ponatinib—CYP2C8—Dapsone—leprosy	0.0239	0.0303	CbGbCtD
Ponatinib—ABCB1—Rifampicin—leprosy	0.0196	0.0248	CbGbCtD
Ponatinib—CYP3A4—Rifampicin—leprosy	0.0117	0.0149	CbGbCtD
Ponatinib—CYP3A4—Dapsone—leprosy	0.00967	0.0123	CbGbCtD
Ponatinib—Phosphorus low—Thalidomide—leprosy	0.00794	0.0805	CcSEcCtD
Ponatinib—FGFR3—appendage—leprosy	0.00664	0.0906	CbGeAlD
Ponatinib—Blood phosphorus decreased—Thalidomide—leprosy	0.0063	0.064	CcSEcCtD
Ponatinib—FGFR3—skin epidermis—leprosy	0.00552	0.0754	CbGeAlD
Ponatinib—KDR—hindlimb—leprosy	0.00397	0.0542	CbGeAlD
Ponatinib—FGFR2—skin epidermis—leprosy	0.00361	0.0493	CbGeAlD
Ponatinib—KDR—appendage—leprosy	0.0034	0.0465	CbGeAlD
Ponatinib—Tumour lysis syndrome—Thalidomide—leprosy	0.0033	0.0334	CcSEcCtD
Ponatinib—Lipase increased—Thalidomide—leprosy	0.00311	0.0316	CcSEcCtD
Ponatinib—KIT—skin epidermis—leprosy	0.00251	0.0343	CbGeAlD
Ponatinib—TEK—blood vessel—leprosy	0.00232	0.0317	CbGeAlD
Ponatinib—SRC—blood vessel—leprosy	0.00206	0.0281	CbGeAlD
Ponatinib—KDR—blood vessel—leprosy	0.00189	0.0259	CbGeAlD
Ponatinib—White blood cell count decreased—Thalidomide—leprosy	0.00184	0.0187	CcSEcCtD
Ponatinib—Embolism venous—Thalidomide—leprosy	0.00181	0.0184	CcSEcCtD
Ponatinib—Lymphopenia—Thalidomide—leprosy	0.00179	0.0181	CcSEcCtD
Ponatinib—FGFR3—skin of body—leprosy	0.00171	0.0234	CbGeAlD
Ponatinib—Skin exfoliation—Dapsone—leprosy	0.00171	0.0173	CcSEcCtD
Ponatinib—BCR—eye—leprosy	0.0017	0.0232	CbGeAlD
Ponatinib—Venous thrombosis—Thalidomide—leprosy	0.00169	0.0172	CcSEcCtD
Ponatinib—KIT—blood vessel—leprosy	0.00168	0.0229	CbGeAlD
Ponatinib—FGFR4—testis—leprosy	0.00158	0.0216	CbGeAlD
Ponatinib—FGFR4—nervous system—leprosy	0.00155	0.0212	CbGeAlD
Ponatinib—Platelet count decreased—Thalidomide—leprosy	0.00154	0.0156	CcSEcCtD
Ponatinib—Febrile neutropenia—Thalidomide—leprosy	0.00152	0.0154	CcSEcCtD
Ponatinib—Deep vein thrombosis—Thalidomide—leprosy	0.0015	0.0153	CcSEcCtD
Ponatinib—Hypercalcaemia—Thalidomide—leprosy	0.00132	0.0134	CcSEcCtD
Ponatinib—FGFR2—eye—leprosy	0.00129	0.0176	CbGeAlD
Ponatinib—Pleural effusion—Thalidomide—leprosy	0.00119	0.0121	CcSEcCtD
Ponatinib—Hyperaesthesia—Thalidomide—leprosy	0.00117	0.0118	CcSEcCtD
Ponatinib—Nasopharyngitis—Dapsone—leprosy	0.00116	0.0118	CcSEcCtD
Ponatinib—Myocardial ischaemia—Thalidomide—leprosy	0.00114	0.0115	CcSEcCtD
Ponatinib—BCR—tendon—leprosy	0.00113	0.0154	CbGeAlD
Ponatinib—FGFR2—skin of body—leprosy	0.00112	0.0153	CbGeAlD
Ponatinib—Petechiae—Thalidomide—leprosy	0.00111	0.0113	CcSEcCtD
Ponatinib—Pancreatitis—Dapsone—leprosy	0.0011	0.0112	CcSEcCtD
Ponatinib—SRC—eye—leprosy	0.0011	0.015	CbGeAlD
Ponatinib—FGFR3—testis—leprosy	0.00108	0.0147	CbGeAlD
Ponatinib—LYN—nervous system—leprosy	0.00106	0.0145	CbGeAlD
Ponatinib—FGFR3—nervous system—leprosy	0.00106	0.0144	CbGeAlD
Ponatinib—KDR—eye—leprosy	0.00101	0.0138	CbGeAlD
Ponatinib—Cellulitis—Thalidomide—leprosy	0.00101	0.0102	CcSEcCtD
Ponatinib—FGFR1—tendon—leprosy	0.001	0.0137	CbGeAlD
Ponatinib—Hypocalcaemia—Thalidomide—leprosy	0.000999	0.0101	CcSEcCtD
Ponatinib—Hyperuricaemia—Thalidomide—leprosy	0.000986	0.01	CcSEcCtD
Ponatinib—Neuropathy peripheral—Dapsone—leprosy	0.00098	0.00994	CcSEcCtD
Ponatinib—Creatinine increased—Thalidomide—leprosy	0.000961	0.00975	CcSEcCtD
Ponatinib—Bone pain—Thalidomide—leprosy	0.000955	0.00969	CcSEcCtD
Ponatinib—SRC—skin of body—leprosy	0.000954	0.013	CbGeAlD
Ponatinib—BCR—testis—leprosy	0.000933	0.0127	CbGeAlD
Ponatinib—Blood uric acid increased—Thalidomide—leprosy	0.000931	0.00945	CcSEcCtD
Ponatinib—FLT3—testis—leprosy	0.000926	0.0126	CbGeAlD
Ponatinib—Neck pain—Thalidomide—leprosy	0.000926	0.0094	CcSEcCtD
Ponatinib—BCR—nervous system—leprosy	0.000915	0.0125	CbGeAlD
Ponatinib—Phosphatase alkaline increased—Thalidomide—leprosy	0.000915	0.00928	CcSEcCtD
Ponatinib—Pulmonary embolism—Thalidomide—leprosy	0.000915	0.00928	CcSEcCtD
Ponatinib—RET—tendon—leprosy	0.000897	0.0122	CbGeAlD
Ponatinib—Skin exfoliation—Thalidomide—leprosy	0.000873	0.00886	CcSEcCtD
Ponatinib—Neuropathy—Thalidomide—leprosy	0.000859	0.00872	CcSEcCtD
Ponatinib—Dry eye—Thalidomide—leprosy	0.000845	0.00857	CcSEcCtD
Ponatinib—FGFR1—testis—leprosy	0.00083	0.0113	CbGeAlD
Ponatinib—TEK—tendon—leprosy	0.000817	0.0112	CbGeAlD
Ponatinib—Sepsis—Thalidomide—leprosy	0.000794	0.00806	CcSEcCtD
Ponatinib—Erythema—Dapsone—leprosy	0.000781	0.00793	CcSEcCtD
Ponatinib—ABL1—eye—leprosy	0.000778	0.0106	CbGeAlD
Ponatinib—KIT—skin of body—leprosy	0.000777	0.0106	CbGeAlD
Ponatinib—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000763	0.00775	CcSEcCtD
Ponatinib—RET—testis—leprosy	0.000743	0.0101	CbGeAlD
Ponatinib—LCK—testis—leprosy	0.000743	0.0101	CbGeAlD
Ponatinib—PDGFRA—tendon—leprosy	0.00074	0.0101	CbGeAlD
Ponatinib—Vision blurred—Dapsone—leprosy	0.000736	0.00747	CcSEcCtD
Ponatinib—Cardiac failure congestive—Thalidomide—leprosy	0.000732	0.00743	CcSEcCtD
Ponatinib—RET—nervous system—leprosy	0.000729	0.00995	CbGeAlD
Ponatinib—ABCB11—testis—leprosy	0.000725	0.00991	CbGeAlD
Ponatinib—FGFR2—testis—leprosy	0.000706	0.00964	CbGeAlD
Ponatinib—Dermatitis exfoliative—Thalidomide—leprosy	0.000704	0.00714	CcSEcCtD
Ponatinib—Atrial fibrillation—Thalidomide—leprosy	0.000701	0.00711	CcSEcCtD
Ponatinib—FGFR2—nervous system—leprosy	0.000693	0.00946	CbGeAlD
Ponatinib—Cough—Dapsone—leprosy	0.000682	0.00692	CcSEcCtD
Ponatinib—Cardiac failure—Thalidomide—leprosy	0.00068	0.00691	CcSEcCtD
Ponatinib—Cerebrovascular accident—Thalidomide—leprosy	0.000678	0.00688	CcSEcCtD
Ponatinib—Lethargy—Thalidomide—leprosy	0.000678	0.00688	CcSEcCtD
Ponatinib—ABL1—skin of body—leprosy	0.000677	0.00924	CbGeAlD
Ponatinib—TEK—testis—leprosy	0.000677	0.00924	CbGeAlD
Ponatinib—KDR—tendon—leprosy	0.000668	0.00912	CbGeAlD
Ponatinib—Hyponatraemia—Thalidomide—leprosy	0.000667	0.00677	CcSEcCtD
Ponatinib—TEK—nervous system—leprosy	0.000664	0.00907	CbGeAlD
Ponatinib—Pain in extremity—Thalidomide—leprosy	0.000664	0.00674	CcSEcCtD
Ponatinib—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000664	0.00674	CcSEcCtD
Ponatinib—Migraine—Thalidomide—leprosy	0.000654	0.00663	CcSEcCtD
Ponatinib—Face oedema—Thalidomide—leprosy	0.000641	0.00651	CcSEcCtD
Ponatinib—Blood creatinine increased—Thalidomide—leprosy	0.000622	0.00631	CcSEcCtD
Ponatinib—Dehydration—Thalidomide—leprosy	0.000617	0.00627	CcSEcCtD
Ponatinib—PDGFRA—testis—leprosy	0.000613	0.00837	CbGeAlD
Ponatinib—Dry skin—Thalidomide—leprosy	0.000609	0.00618	CcSEcCtD
Ponatinib—Hypokalaemia—Thalidomide—leprosy	0.000604	0.00613	CcSEcCtD
Ponatinib—PDGFRA—nervous system—leprosy	0.000602	0.00822	CbGeAlD
Ponatinib—SRC—testis—leprosy	0.000601	0.00821	CbGeAlD
Ponatinib—Breast disorder—Thalidomide—leprosy	0.0006	0.00609	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000598	0.00607	CcSEcCtD
Ponatinib—SRC—nervous system—leprosy	0.00059	0.00806	CbGeAlD
Ponatinib—Alanine aminotransferase increased—Thalidomide—leprosy	0.000586	0.00594	CcSEcCtD
Ponatinib—Abdominal distension—Thalidomide—leprosy	0.000578	0.00586	CcSEcCtD
Ponatinib—Insomnia—Dapsone—leprosy	0.000577	0.00585	CcSEcCtD
Ponatinib—Pancreatitis—Thalidomide—leprosy	0.000563	0.00571	CcSEcCtD
Ponatinib—Angina pectoris—Thalidomide—leprosy	0.000559	0.00567	CcSEcCtD
Ponatinib—KDR—testis—leprosy	0.000553	0.00755	CbGeAlD
Ponatinib—Pancytopenia—Thalidomide—leprosy	0.000545	0.00553	CcSEcCtD
Ponatinib—KDR—nervous system—leprosy	0.000543	0.00741	CbGeAlD
Ponatinib—Neutropenia—Thalidomide—leprosy	0.000537	0.00545	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Thalidomide—leprosy	0.000533	0.00541	CcSEcCtD
Ponatinib—Erectile dysfunction—Thalidomide—leprosy	0.000529	0.00536	CcSEcCtD
Ponatinib—Gastrointestinal pain—Dapsone—leprosy	0.000521	0.00529	CcSEcCtD
Ponatinib—Weight decreased—Thalidomide—leprosy	0.000519	0.00527	CcSEcCtD
Ponatinib—Hyperglycaemia—Thalidomide—leprosy	0.000518	0.00525	CcSEcCtD
Ponatinib—ABL1—tendon—leprosy	0.000515	0.00704	CbGeAlD
Ponatinib—Pneumonia—Thalidomide—leprosy	0.000515	0.00522	CcSEcCtD
Ponatinib—Infestation NOS—Thalidomide—leprosy	0.000512	0.00519	CcSEcCtD
Ponatinib—Infestation—Thalidomide—leprosy	0.000512	0.00519	CcSEcCtD
Ponatinib—Acute coronary syndrome—Thalidomide—leprosy	0.000504	0.00512	CcSEcCtD
Ponatinib—Abdominal pain—Dapsone—leprosy	0.000504	0.00511	CcSEcCtD
Ponatinib—Body temperature increased—Dapsone—leprosy	0.000504	0.00511	CcSEcCtD
Ponatinib—Neuropathy peripheral—Thalidomide—leprosy	0.000502	0.00509	CcSEcCtD
Ponatinib—Myocardial infarction—Thalidomide—leprosy	0.000502	0.00509	CcSEcCtD
Ponatinib—Stomatitis—Thalidomide—leprosy	0.000499	0.00506	CcSEcCtD
Ponatinib—KIT—testis—leprosy	0.00049	0.00669	CbGeAlD
Ponatinib—Epistaxis—Thalidomide—leprosy	0.000483	0.0049	CcSEcCtD
Ponatinib—KIT—nervous system—leprosy	0.000481	0.00657	CbGeAlD
Ponatinib—Hypoaesthesia—Thalidomide—leprosy	0.000457	0.00464	CcSEcCtD
Ponatinib—ABCB1—blood vessel—leprosy	0.000455	0.00621	CbGeAlD
Ponatinib—Oedema peripheral—Thalidomide—leprosy	0.000452	0.00459	CcSEcCtD
Ponatinib—Visual impairment—Thalidomide—leprosy	0.000443	0.00449	CcSEcCtD
Ponatinib—Eye disorder—Thalidomide—leprosy	0.000429	0.00436	CcSEcCtD
Ponatinib—ABL1—testis—leprosy	0.000427	0.00583	CbGeAlD
Ponatinib—Cardiac disorder—Thalidomide—leprosy	0.000426	0.00433	CcSEcCtD
Ponatinib—ABL1—nervous system—leprosy	0.000419	0.00572	CbGeAlD
Ponatinib—Angiopathy—Thalidomide—leprosy	0.000417	0.00423	CcSEcCtD
Ponatinib—Mediastinal disorder—Thalidomide—leprosy	0.000414	0.0042	CcSEcCtD
Ponatinib—Chills—Thalidomide—leprosy	0.000412	0.00418	CcSEcCtD
Ponatinib—Arrhythmia—Thalidomide—leprosy	0.00041	0.00416	CcSEcCtD
Ponatinib—Alopecia—Thalidomide—leprosy	0.000406	0.00412	CcSEcCtD
Ponatinib—Vomiting—Dapsone—leprosy	0.000405	0.00411	CcSEcCtD
Ponatinib—Mental disorder—Thalidomide—leprosy	0.000402	0.00408	CcSEcCtD
Ponatinib—Malnutrition—Thalidomide—leprosy	0.0004	0.00406	CcSEcCtD
Ponatinib—Headache—Dapsone—leprosy	0.000399	0.00405	CcSEcCtD
Ponatinib—Back pain—Thalidomide—leprosy	0.000387	0.00393	CcSEcCtD
Ponatinib—Muscle spasms—Thalidomide—leprosy	0.000384	0.0039	CcSEcCtD
Ponatinib—Nausea—Dapsone—leprosy	0.000379	0.00384	CcSEcCtD
Ponatinib—Vision blurred—Thalidomide—leprosy	0.000377	0.00382	CcSEcCtD
Ponatinib—Anaemia—Thalidomide—leprosy	0.00037	0.00375	CcSEcCtD
Ponatinib—Leukopenia—Thalidomide—leprosy	0.000358	0.00363	CcSEcCtD
Ponatinib—Cough—Thalidomide—leprosy	0.000349	0.00354	CcSEcCtD
Ponatinib—Hypertension—Thalidomide—leprosy	0.000345	0.0035	CcSEcCtD
Ponatinib—Arthralgia—Thalidomide—leprosy	0.00034	0.00346	CcSEcCtD
Ponatinib—Myalgia—Thalidomide—leprosy	0.00034	0.00346	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000338	0.00343	CcSEcCtD
Ponatinib—Dry mouth—Thalidomide—leprosy	0.000333	0.00338	CcSEcCtD
Ponatinib—Oedema—Thalidomide—leprosy	0.000326	0.00331	CcSEcCtD
Ponatinib—Infection—Thalidomide—leprosy	0.000324	0.00329	CcSEcCtD
Ponatinib—Nervous system disorder—Thalidomide—leprosy	0.00032	0.00325	CcSEcCtD
Ponatinib—Thrombocytopenia—Thalidomide—leprosy	0.00032	0.00324	CcSEcCtD
Ponatinib—Skin disorder—Thalidomide—leprosy	0.000317	0.00322	CcSEcCtD
Ponatinib—Hyperhidrosis—Thalidomide—leprosy	0.000315	0.0032	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Thalidomide—leprosy	0.000297	0.00302	CcSEcCtD
Ponatinib—Insomnia—Thalidomide—leprosy	0.000295	0.003	CcSEcCtD
Ponatinib—Paraesthesia—Thalidomide—leprosy	0.000293	0.00297	CcSEcCtD
Ponatinib—Dyspnoea—Thalidomide—leprosy	0.000291	0.00295	CcSEcCtD
Ponatinib—Dyspepsia—Thalidomide—leprosy	0.000287	0.00292	CcSEcCtD
Ponatinib—Decreased appetite—Thalidomide—leprosy	0.000284	0.00288	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Thalidomide—leprosy	0.000282	0.00286	CcSEcCtD
Ponatinib—Fatigue—Thalidomide—leprosy	0.000281	0.00286	CcSEcCtD
Ponatinib—Pain—Thalidomide—leprosy	0.000279	0.00283	CcSEcCtD
Ponatinib—Constipation—Thalidomide—leprosy	0.000279	0.00283	CcSEcCtD
Ponatinib—CYP2C8—testis—leprosy	0.000277	0.00378	CbGeAlD
Ponatinib—ABCG2—testis—leprosy	0.000269	0.00367	CbGeAlD
Ponatinib—Gastrointestinal pain—Thalidomide—leprosy	0.000267	0.00271	CcSEcCtD
Ponatinib—Abdominal pain—Thalidomide—leprosy	0.000258	0.00262	CcSEcCtD
Ponatinib—Body temperature increased—Thalidomide—leprosy	0.000258	0.00262	CcSEcCtD
Ponatinib—Asthenia—Thalidomide—leprosy	0.000234	0.00238	CcSEcCtD
Ponatinib—Pruritus—Thalidomide—leprosy	0.000231	0.00234	CcSEcCtD
Ponatinib—Diarrhoea—Thalidomide—leprosy	0.000223	0.00227	CcSEcCtD
Ponatinib—Dizziness—Thalidomide—leprosy	0.000216	0.00219	CcSEcCtD
Ponatinib—Vomiting—Thalidomide—leprosy	0.000207	0.00211	CcSEcCtD
Ponatinib—Rash—Thalidomide—leprosy	0.000206	0.00209	CcSEcCtD
Ponatinib—Dermatitis—Thalidomide—leprosy	0.000206	0.00209	CcSEcCtD
Ponatinib—Headache—Thalidomide—leprosy	0.000204	0.00207	CcSEcCtD
Ponatinib—Nausea—Thalidomide—leprosy	0.000194	0.00197	CcSEcCtD
Ponatinib—CYP2D6—testis—leprosy	0.000184	0.00252	CbGeAlD
Ponatinib—CYP3A4—nervous system—leprosy	0.000184	0.00251	CbGeAlD
Ponatinib—CYP2D6—nervous system—leprosy	0.000181	0.00247	CbGeAlD
Ponatinib—ABCB1—testis—leprosy	0.000133	0.00181	CbGeAlD
Ponatinib—ABCB1—nervous system—leprosy	0.00013	0.00178	CbGeAlD
Ponatinib—KIT—Innate Immune System—RIPK2—leprosy	7.57e-05	0.00187	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—TLR2—leprosy	7.57e-05	0.00187	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—RIPK2—leprosy	7.4e-05	0.00183	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—RIPK2—leprosy	7.27e-05	0.0018	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—IL2—leprosy	7.25e-05	0.00179	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—TLR2—leprosy	7.18e-05	0.00178	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—RIPK2—leprosy	7.18e-05	0.00178	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—RIPK2—leprosy	7.17e-05	0.00177	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—TLR2—leprosy	7.17e-05	0.00177	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CYLD—leprosy	7.12e-05	0.00176	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—NOD2—leprosy	6.99e-05	0.00173	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CYLD—leprosy	6.97e-05	0.00172	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	6.96e-05	0.00172	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—RIPK2—leprosy	6.9e-05	0.00171	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—RIPK2—leprosy	6.88e-05	0.0017	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—NOD2—leprosy	6.86e-05	0.0017	CbGpPWpGaD
Ponatinib—KIT—Immune System—CYLD—leprosy	6.84e-05	0.00169	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—PARK2—leprosy	6.82e-05	0.00169	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CD40LG—leprosy	6.76e-05	0.00167	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CD8A—leprosy	6.69e-05	0.00166	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—HLA-DRB1—leprosy	6.64e-05	0.00164	CbGpPWpGaD
Ponatinib—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	6.62e-05	0.00164	CbGpPWpGaD
Ponatinib—FGFR4—Innate Immune System—CD4—leprosy	6.59e-05	0.00163	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—RIPK2—leprosy	6.53e-05	0.00162	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—TLR2—leprosy	6.53e-05	0.00162	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—NOD2—leprosy	6.51e-05	0.00161	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—NOD2—leprosy	6.5e-05	0.00161	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CYLD—leprosy	6.49e-05	0.00161	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CYLD—leprosy	6.48e-05	0.0016	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—CD4—leprosy	6.33e-05	0.00157	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—RIPK2—leprosy	6.32e-05	0.00156	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—TLR2—leprosy	6.32e-05	0.00156	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—RIPK2—leprosy	6.29e-05	0.00156	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—TLR2—leprosy	6.29e-05	0.00156	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—SDHD—leprosy	6.24e-05	0.00154	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—PARK2—leprosy	6.16e-05	0.00152	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—RIPK2—leprosy	6.07e-05	0.0015	CbGpPWpGaD
Ponatinib—KIT—Immune System—PARK2—leprosy	6.05e-05	0.0015	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—PARK2—leprosy	6.04e-05	0.0015	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—IFNG—leprosy	6e-05	0.00149	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—NOD2—leprosy	5.92e-05	0.00146	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—PARK2—leprosy	5.74e-05	0.00142	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—NOD2—leprosy	5.73e-05	0.00142	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—PARK2—leprosy	5.73e-05	0.00142	CbGpPWpGaD
Ponatinib—LYN—Immune System—CYLD—leprosy	5.71e-05	0.00141	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—RIPK2—leprosy	5.71e-05	0.00141	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—NOD2—leprosy	5.7e-05	0.00141	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	5.7e-05	0.00141	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CYLD—leprosy	5.69e-05	0.00141	CbGpPWpGaD
Ponatinib—FGFR2—Disease—SLC11A1—leprosy	5.69e-05	0.00141	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—CD40LG—leprosy	5.67e-05	0.0014	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TNF—leprosy	5.62e-05	0.00139	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—CD8A—leprosy	5.61e-05	0.00139	CbGpPWpGaD
Ponatinib—KIT—Disease—SLC11A1—leprosy	5.58e-05	0.00138	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—CD40LG—leprosy	5.57e-05	0.00138	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—CD8A—leprosy	5.51e-05	0.00136	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—IL2—leprosy	5.45e-05	0.00135	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—HLA-DRB1—leprosy	5.45e-05	0.00135	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—IL2—leprosy	5.33e-05	0.00132	CbGpPWpGaD
Ponatinib—FGFR1—Disease—SLC11A1—leprosy	5.3e-05	0.00131	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD40LG—leprosy	5.29e-05	0.00131	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—SLC11A1—leprosy	5.29e-05	0.00131	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD40LG—leprosy	5.27e-05	0.00131	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD8A—leprosy	5.23e-05	0.00129	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD8A—leprosy	5.21e-05	0.00129	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—RIPK2—leprosy	5.18e-05	0.00128	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—TLR2—leprosy	5.18e-05	0.00128	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—IFNG—leprosy	5.08e-05	0.00126	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	5.07e-05	0.00126	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—leprosy	5.06e-05	0.00125	CbGpPWpGaD
Ponatinib—LYN—Immune System—PARK2—leprosy	5.05e-05	0.00125	CbGpPWpGaD
Ponatinib—BCR—Disease—CD4—leprosy	5.03e-05	0.00125	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PARK2—leprosy	5.03e-05	0.00124	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD40LG—leprosy	5e-05	0.00124	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—RIPK2—leprosy	4.97e-05	0.00123	CbGpPWpGaD
Ponatinib—LCK—HIV Infection—CD4—leprosy	4.95e-05	0.00122	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD8A—leprosy	4.95e-05	0.00122	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—CD4—leprosy	4.88e-05	0.00121	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—NOD2—leprosy	4.7e-05	0.00116	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—CD4—leprosy	4.68e-05	0.00116	CbGpPWpGaD
Ponatinib—LCK—Immune System—CYLD—leprosy	4.68e-05	0.00116	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD40LG—leprosy	4.65e-05	0.00115	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD8A—leprosy	4.6e-05	0.00114	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—RIPK2—leprosy	4.59e-05	0.00114	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—TLR2—leprosy	4.59e-05	0.00114	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—HLA-DRB1—leprosy	4.57e-05	0.00113	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—IL2—leprosy	4.51e-05	0.00112	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—RIPK2—leprosy	4.49e-05	0.00111	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—TLR2—leprosy	4.49e-05	0.00111	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—HLA-DRB1—leprosy	4.49e-05	0.00111	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—IL2—leprosy	4.47e-05	0.00111	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	4.44e-05	0.0011	CbGpPWpGaD
Ponatinib—KIT—Immune System—RIPK2—leprosy	4.41e-05	0.00109	CbGpPWpGaD
Ponatinib—KIT—Immune System—TLR2—leprosy	4.41e-05	0.00109	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—RIPK2—leprosy	4.4e-05	0.00109	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—HLA-DRB1—leprosy	4.26e-05	0.00105	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—HLA-DRB1—leprosy	4.25e-05	0.00105	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—RIPK2—leprosy	4.22e-05	0.00104	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—RIPK2—leprosy	4.18e-05	0.00104	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—TLR2—leprosy	4.18e-05	0.00104	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—RIPK2—leprosy	4.17e-05	0.00103	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—TLR2—leprosy	4.17e-05	0.00103	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—IFNG—leprosy	4.16e-05	0.00103	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—NOD2—leprosy	4.16e-05	0.00103	CbGpPWpGaD
Ponatinib—SRC—Immune System—CYLD—leprosy	4.15e-05	0.00103	CbGpPWpGaD
Ponatinib—LCK—Immune System—PARK2—leprosy	4.14e-05	0.00102	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—SDHD—leprosy	4.12e-05	0.00102	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—NOD2—leprosy	4.07e-05	0.00101	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—HLA-DRB1—leprosy	4.03e-05	0.000997	CbGpPWpGaD
Ponatinib—KIT—Immune System—NOD2—leprosy	4e-05	0.000989	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—IFNG—leprosy	3.98e-05	0.000984	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—IL2—leprosy	3.96e-05	0.00098	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—TNF—leprosy	3.88e-05	0.000961	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CD4—leprosy	3.84e-05	0.000951	CbGpPWpGaD
Ponatinib—LCK—Disease—SLC11A1—leprosy	3.82e-05	0.000946	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD40LG—leprosy	3.81e-05	0.000944	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—NOD2—leprosy	3.79e-05	0.000939	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—NOD2—leprosy	3.78e-05	0.000936	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD8A—leprosy	3.77e-05	0.000933	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—HLA-DRB1—leprosy	3.75e-05	0.000927	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—IL2—leprosy	3.7e-05	0.000916	CbGpPWpGaD
Ponatinib—LYN—Immune System—RIPK2—leprosy	3.68e-05	0.000911	CbGpPWpGaD
Ponatinib—LYN—Immune System—TLR2—leprosy	3.68e-05	0.000911	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—RIPK2—leprosy	3.68e-05	0.00091	CbGpPWpGaD
Ponatinib—SRC—Immune System—PARK2—leprosy	3.66e-05	0.000907	CbGpPWpGaD
Ponatinib—ABL1—Immune System—RIPK2—leprosy	3.66e-05	0.000907	CbGpPWpGaD
Ponatinib—ABL1—Immune System—TLR2—leprosy	3.66e-05	0.000907	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	3.58e-05	0.000886	CbGpPWpGaD
Ponatinib—FGFR4—Disease—CD4—leprosy	3.55e-05	0.000878	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—IL2—leprosy	3.53e-05	0.000875	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD40LG—leprosy	3.44e-05	0.000852	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD8A—leprosy	3.4e-05	0.000842	CbGpPWpGaD
Ponatinib—SRC—Disease—SLC11A1—leprosy	3.38e-05	0.000837	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD40LG—leprosy	3.38e-05	0.000836	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD40LG—leprosy	3.38e-05	0.000835	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—CD4—leprosy	3.35e-05	0.00083	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD8A—leprosy	3.34e-05	0.000827	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD8A—leprosy	3.34e-05	0.000826	CbGpPWpGaD
Ponatinib—LYN—Immune System—NOD2—leprosy	3.34e-05	0.000826	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NOD2—leprosy	3.32e-05	0.000822	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—CD4—leprosy	3.29e-05	0.000816	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—IL2—leprosy	3.24e-05	0.000803	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—leprosy	3.24e-05	0.000802	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—TNF—leprosy	3.22e-05	0.000798	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—CD4—leprosy	3.22e-05	0.000797	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD40LG—leprosy	3.21e-05	0.000794	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD40LG—leprosy	3.2e-05	0.000792	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD8A—leprosy	3.17e-05	0.000785	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—CD4—leprosy	3.16e-05	0.000783	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD8A—leprosy	3.16e-05	0.000783	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—CD4—leprosy	3.13e-05	0.000774	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—CD4—leprosy	3.12e-05	0.000772	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—HLA-DRB1—leprosy	3.07e-05	0.00076	CbGpPWpGaD
Ponatinib—LCK—Immune System—RIPK2—leprosy	3.02e-05	0.000747	CbGpPWpGaD
Ponatinib—LCK—Immune System—TLR2—leprosy	3.02e-05	0.000747	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CD4—leprosy	3e-05	0.000743	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CD4—leprosy	3e-05	0.000741	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—SDHD—leprosy	2.96e-05	0.000732	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IFNG—leprosy	2.94e-05	0.000728	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—RIPK2—leprosy	2.9e-05	0.000718	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—RIPK2—leprosy	2.85e-05	0.000706	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CD4—leprosy	2.84e-05	0.000703	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD40LG—leprosy	2.82e-05	0.000698	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—IL2—leprosy	2.81e-05	0.000696	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD40LG—leprosy	2.81e-05	0.000695	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—IL2—leprosy	2.8e-05	0.000693	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD8A—leprosy	2.79e-05	0.000691	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD8A—leprosy	2.78e-05	0.000687	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—HLA-DRB1—leprosy	2.77e-05	0.000686	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—CD4—leprosy	2.75e-05	0.000681	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—CD4—leprosy	2.74e-05	0.000678	CbGpPWpGaD
Ponatinib—LCK—Immune System—NOD2—leprosy	2.74e-05	0.000677	CbGpPWpGaD
Ponatinib—KIT—Immune System—HLA-DRB1—leprosy	2.72e-05	0.000673	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—HLA-DRB1—leprosy	2.72e-05	0.000673	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—RIPK2—leprosy	2.71e-05	0.00067	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—RIPK2—leprosy	2.7e-05	0.000668	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR2—leprosy	2.67e-05	0.000661	CbGpPWpGaD
Ponatinib—SRC—Immune System—RIPK2—leprosy	2.67e-05	0.000661	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD4—leprosy	2.64e-05	0.000654	CbGpPWpGaD
Ponatinib—FGFR3—Disease—CD4—leprosy	2.62e-05	0.000649	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL2—leprosy	2.61e-05	0.000647	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—HLA-DRB1—leprosy	2.58e-05	0.000639	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—HLA-DRB1—leprosy	2.58e-05	0.000637	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—SDHD—leprosy	2.56e-05	0.000634	CbGpPWpGaD
Ponatinib—SRC—Immune System—NOD2—leprosy	2.42e-05	0.000599	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RIPK2—leprosy	2.38e-05	0.000589	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—leprosy	2.37e-05	0.000587	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD40LG—leprosy	2.31e-05	0.000572	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—IL2—leprosy	2.3e-05	0.00057	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD8A—leprosy	2.29e-05	0.000566	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL2—leprosy	2.28e-05	0.000566	CbGpPWpGaD
Ponatinib—LYN—Immune System—HLA-DRB1—leprosy	2.27e-05	0.000562	CbGpPWpGaD
Ponatinib—ABL1—Immune System—HLA-DRB1—leprosy	2.26e-05	0.00056	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—CD4—leprosy	2.25e-05	0.000558	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—SDHD—leprosy	2.23e-05	0.000552	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD4—leprosy	2.17e-05	0.000536	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—SDHD—leprosy	2.1e-05	0.00052	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—leprosy	2.09e-05	0.000517	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—leprosy	2.08e-05	0.000514	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD40LG—leprosy	2.05e-05	0.000507	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—IL2—leprosy	2.04e-05	0.000505	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD8A—leprosy	2.02e-05	0.000501	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IFNG—leprosy	2.02e-05	0.000501	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CD4—leprosy	2e-05	0.000494	CbGpPWpGaD
Ponatinib—KIT—Immune System—IFNG—leprosy	1.99e-05	0.000492	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD4—leprosy	1.95e-05	0.000484	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RIPK2—leprosy	1.95e-05	0.000483	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD4—leprosy	1.92e-05	0.000475	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD4—leprosy	1.92e-05	0.000474	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.92e-05	0.000474	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IFNG—leprosy	1.89e-05	0.000467	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IFNG—leprosy	1.88e-05	0.000466	CbGpPWpGaD
Ponatinib—LCK—Immune System—HLA-DRB1—leprosy	1.86e-05	0.000461	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD4—leprosy	1.82e-05	0.000451	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD4—leprosy	1.82e-05	0.00045	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CD4—leprosy	1.8e-05	0.000447	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL2—leprosy	1.8e-05	0.000445	CbGpPWpGaD
Ponatinib—KIT—Disease—CD4—leprosy	1.77e-05	0.000439	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL2—leprosy	1.77e-05	0.000437	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RIPK2—leprosy	1.73e-05	0.000427	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL2—leprosy	1.69e-05	0.000418	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CD4—leprosy	1.68e-05	0.000416	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CD4—leprosy	1.68e-05	0.000415	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL2—leprosy	1.68e-05	0.000415	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL2—leprosy	1.67e-05	0.000414	CbGpPWpGaD
Ponatinib—LYN—Immune System—IFNG—leprosy	1.66e-05	0.000411	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IFNG—leprosy	1.65e-05	0.000409	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DRB1—leprosy	1.65e-05	0.000408	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD4—leprosy	1.6e-05	0.000397	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD4—leprosy	1.59e-05	0.000395	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—leprosy	1.51e-05	0.000375	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL2—leprosy	1.47e-05	0.000365	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL2—leprosy	1.47e-05	0.000364	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL2—leprosy	1.47e-05	0.000363	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SDHD—leprosy	1.37e-05	0.00034	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—leprosy	1.36e-05	0.000337	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—leprosy	1.31e-05	0.000325	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—leprosy	1.21e-05	0.0003	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2—leprosy	1.21e-05	0.000299	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—leprosy	1.2e-05	0.000298	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—leprosy	1.16e-05	0.000288	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2—leprosy	1.16e-05	0.000288	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2—leprosy	1.14e-05	0.000283	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2—leprosy	1.08e-05	0.000268	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2—leprosy	1.08e-05	0.000267	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—leprosy	1.07e-05	0.000266	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2—leprosy	1.07e-05	0.000265	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2—leprosy	9.53e-06	0.000236	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2—leprosy	7.81e-06	0.000193	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2—leprosy	6.92e-06	0.000171	CbGpPWpGaD
